In in vivo experiments, we confirmed that properdin knockout or myeloid cell-conditional properdin knockout improved stroke outcomes, which were associated with the suppression of excessive neuroinflammation, suggesting that inhibition of properdin is beneficial for ischemic stroke recovery. The gene discussed is CFP; the disease is ischemic stroke.